Markets

News Details

( 09 May 2018)
Cipla - Press Release

Cipla Limited has informed the Exchange regarding a press release dated May 09, 2018, titled "Cipla Receives Final Approval for Generic Vazculepr, Generic Phenylephrine Hydrochloride Injection USP, 10 mg/mL Single-Dose Vial and Generic Aromasinr".